Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Allison

Showing results (231-240 of 239) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 239 results.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Nature|June 17, 2016
Bright spots among the world’s coral reefsJoshua E Cinner, Cindy Huchery, M Aaron MacNeil, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further ResearchShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Science (New York, N.Y.)|October 28, 2021
WTO must ban harmful fisheries subsidiesU Rashid Sumaila, Daniel J Skerritt, Anna Schuhbauer, et al.
Pageof 24

Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Nature|June 17, 2016
Bright spots among the world’s coral reefsJoshua E Cinner, Cindy Huchery, M Aaron MacNeil, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further ResearchShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Science (New York, N.Y.)|October 28, 2021
WTO must ban harmful fisheries subsidiesU Rashid Sumaila, Daniel J Skerritt, Anna Schuhbauer, et al.
Pageof 24